Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe, Americas, and Africa, Asia & Australia. The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.

BTG acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. British Technology Group International that began operation in 1948 became BTG in March 1995. Its headquarters is in London in the United Kingdom.

We are passionate and moved by a cause: to make precision medicine a reality in ventilation to benefit patients, caregivers, hospitals and payers. With a highly qualified multidisciplinary team, we focus on the development of state-of-the-art ventilation! We are disruptive, in constant evolution: We promote a strong partnership between academy and industry. Invested by FinHealth, a private equity and venture capital fund manager focused exclusively on health investments, we also received support from FAPESP and FINEP, brazilian public research companies.

Swisstom AG, located in Landquart, Switzerland, develops and manufactures innovative medical devices. Their new lung function monitor enables life-saving treatments for patients in intensive care and during general anesthesia. Unlike traditional tomography, Swisstom´s bedside imaging is based on non-radiating principles: Electrical Impedance Tomography (EIT). To date, no comparable devices can show such regional organ function continuously and in real-time at the patient’s bedside. Swisstom creates its competitive edge by passionate leadership in non-invasive tomography with the goal to improve individual lives and therapies.

Silan Technology (Chengdu) Co., Ltd., established on 2012-01-31, Business scope includes research and development,Wholesale Electronics,Instrumentation,computer software and provide technical advice,Technology Transfer and Technical Services,Sales of medical devices(Class I and Class II).(The above business scope does not include items restricted or prohibited by national laws and regulations,Except those involving the implementation of special access management measures stipulated by the state,Those involving licenses can only carry out business activities with the relevant licenses).

BiLab provides cardiopulmonary monitoring with its technology of electrical impedance tomography.

Dr��ger Medical AG & Co. KG manufactures medical equipment. The firm's products include Anesthesia workstations, monitoring systems, enterprise solutions, information technologies, ventilation therapy, home mechanical ventilation, warming therapy, architectural systems, accessories, surgical lighting and video systems. It offers services in the fields of emergency, perioperative, critical, perinatal, and home care. The company was founded in 1889 and is headquartered in Luebeck, Germany.

CSEM is a private, non profit Swiss company for applied research, including technology, strategy and innovation consulting, focused on generating value for a sustainable world. They aim to be one of the best innovation centers worldwide, providing novel applications and solutions to their customers by developing and applying their technology platforms in micro-, nano- and information technologies, thus adding value to the results of research. Their research activities - financed by public funds - combined with the research results of their academic partners, help us to develop their technology platforms for the benefit of their industrial customers and their start-ups. They are aware that collaborating with other innovation centers and research entities is crucial. With this in mind, they have built up a strong national and international network. They work together with CEA/Léti in France, the Fraunhofer Gesellschaft (Mikroelektronische Allianz) in Germany and VTT in Finland. Together with these institutions, CSEM created HTA (Heterogeneous Technology Alliance), to prepare for the next generation of technology. Their research strategy is based on extensive market research, and helps us to develop technologies today which will be needed in the future. While research activities remain one of the cornerstones of CSEM, they never lose sight of the overriding importance of their customers - it is they who provide us with invaluable insights into global markets.

Dianqi Biomedical Technology (Beijing) Co., Ltd., established on 2020-09-07, Business scope includes technology development,technology transfer,Technical Services,technical consulting,Technology Promotion;Business Management Consulting;Economic and Trade Consulting;Medical Research(Does not include medical activities);health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval);Computer System Services;Basic software service;Application software service(Does not contain medical software);selling computers,Software and Auxiliary Equipment,electronic product,Equipment,Instrumentation,Ι,Class II medical device;Technology Import and Export,Import and export;Sales of Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Part of Becton, Dickinson & Co., Carefusion 205, Inc. is an American company located in Lakewood, OH. The firm manufactures sleep therapy devices. It was acquired by VIASYS Healthcare, Inc. on July 12, 2006 for $24.32 million.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Baker Hughes, Inc. is a private company headquartered in Houston, TX. The firm manufactures oilfield equipment.

MPT-IRIS provides geophysical monitoring equipment and services.

Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.

Beijing Huarui Boshi Medical Imaging Technology Co. Ltd. is a Chinese company. The firm provides electrical impedance tomography technology services.

Part of Sulzer AG, Sulzer Pumpen AG is a company headquartered in Winterthur, Switzerland. The firm manufactures and distributes centrifugal pumps.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Vaisala Oyj engages in the development and manufacture of electronic measuring systems and instruments. It operates through the Weather and Environment Business Area; and Industrial Measurements Business Area segments. The Weather and Environment Business Area segment serves weather dependent markets and customers. The Industrial Measurements Business Area segment focuses on customers who operate in industries in which the monitoring of conditions is crucial. The company was founded by Vilho Väisälä in 1936 and is headquartered in Vantaa, Finland.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.